SCHEMBL2202249

SCHEMBL2202249

COC(=O)c1nc2n(c(=O)c1O)CCN(C)CC2N(C)Cc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
MAPT P10636 2/20 0.43
HSP90AA1 P07900 1/20 0.43
HTT P42858 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
RNASEH1 O60930 1/20 0.39
KCNH2 Q12809 1/20 0.38
CYP2C9 P11712 1/20 0.38
ERCC1 P07992 1/20 0.35
FEN1 P39748 1/20 0.35
ERCC4 Q92889 1/20 0.35
JAK2 O60674 1/20 0.35
JAK1 P23458 1/20 0.35
KMT2A Q03164 1/20 0.34
DDB1 Q16531 1/20 0.33
CRBN Q96SW2 1/20 0.33
OPRM1 P35372 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
HPGD P15428 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2206742 0.89 ALDH1A1 (0.42) ALDH1A1MAPTHSP90AA1HTTSMN1; SMN2
SCHEMBL2208599 0.86 JAK2 (0.49) ALDH1A1MAPTHSP90AA1HTTSMN1; SMN2
Hydrochloric Acid SCHEMBL1751097 0.86 KCNH2 (0.47) ALDH1A1MAPTHSP90AA1HTTSMN1; SMN2
SCHEMBL2209573 0.84 ALDH1A1 (0.42) ALDH1A1MAPTHSP90AA1HTTSMN1; SMN2
SCHEMBL2207919 0.83 KCNH2 (0.59) ALDH1A1SMN1; SMN2KCNH2CYP2C9ERCC1
SCHEMBL2207964 0.79 CYP2C9 (0.47) KCNH2CYP2C9
SCHEMBL2206687 0.73 NPSR1 (0.32) RNASEH1ERCC1FEN1ERCC4NPSR1
SCHEMBL2205093 0.73 CYP2C9 (0.64) ALDH1A1SMN1; SMN2KCNH2CYP2C9ERCC1
SCHEMBL2209617 0.73 KCNH2 (0.58) ALDH1A1SMN1; SMN2KCNH2CYP2C9ERCC1
SCHEMBL2205871 0.73 KCNH2 (0.56) ALDH1A1SMN1; SMN2KCNH2CYP2C9ERCC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110257162-A1 HIV INTEGRASE INHIBITORS SUMMA VINCENZO 2011-10-20 US disclosed
US-7981879-B2 HIV integrase inhibitors Instituto di Ricerchi di Biologia Molecolare P. Angeletti S.p.A. (IT) 2011-07-19 US disclosed
US-20090253681-A1 HIV Integrase Inhibitors MSD ITALIA S.R.L. (IT) 2009-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257162-A1 HIV INTEGRASE INHIBITORS REV1, CDK9, INTS9 ALDH1A1 4016/4885MAPT 2670/4885HSP90AA1 3958/4885
US-20090253681-A1 HIV Integrase Inhibitors REV1, INTS9, H1-10 ALDH1A1 4120/4885MAPT 3157/4885HSP90AA1 2992/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.